Berthold Hackl
Directeur Général chez Sorrento Investment GmbH
Profil
Berthold Hackl is currently the Co-Managing Director at Sorrento Investment GmbH.
He previously held positions such as Chief Executive Officer at Ambu Innovation GmbH, Non-Executive Director at Arthro Kinetics Ltd., Director-Supervisory Board at mtm laboratories AG, Co-Managing Director at Eurofins BioPharma Services Holding Germany GmbH, and Director at Luciole Medical AG.
He was also the Managing Partner at Heidelberg Innovation Fonds Management GmbH from 2000 to 2007 and a Member-Supervisory Board at Arthro Kinetics AG.
Mr. Hackl received his undergraduate degree from the University of Freiburg and his MBA from INSEAD.
Postes actifs de Berthold Hackl
| Sociétés | Poste | Début |
|---|---|---|
Sorrento Investment GmbH
 Sorrento Investment GmbH MiscellaneousMiscellaneous Sorrento Investment GmbH operates as a holding company. The company was founded in May 2006 and is headquartered in Kronberg im Taunus, Germany. | Directeur Général | 08/07/2011 |
Anciens postes connus de Berthold Hackl
| Sociétés | Poste | Fin |
|---|---|---|
mtm laboratories AG
 mtm laboratories AG Medical SpecialtiesHealth Technology mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec® Histology kit and CINtec® Cytology kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4™ antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results. mtm laboratories AG also has programs to identify and develop biomarker based diagnostics for other cancer indications. With its extensive and ever increasing network of clinical research institutions, academic research organizations, and medical professionals active in the field of oncology and molecular pathology, mtm has established a rapid, integrated process for the successful identification and clinical validation of molecular markers associated with cancer. | Directeur/Membre du Conseil | 02/12/2013 |
Arthro Kinetics Ltd.
 Arthro Kinetics Ltd. Medical SpecialtiesHealth Technology Arthro Kinetics develops manufactures and markets advanced biological implants for joint regeneration and surgical instrument and access systems for endoscopic spine surgery. The Company aims to develop a portfolio of biological implants for insertion by endoscopic spine surgery techniques, thereby setting new standards of surgical care. The Company has developed and is marketing CaReS, its first biological cartilage repair product, and K.I.S.S., its comprehensive spinal surgical instruments system for endoscopic spinal access and surgical intervention. | Directeur/Membre du Conseil | 20/07/2011 |
Heidelberg Innovation Fonds Management GmbH
 Heidelberg Innovation Fonds Management GmbH Investment ManagersFinance Heidelberg Innovation Fonds Management GmbH (Heidelberg Innovation) is an independent German venture capital firm which was founded in 1997 by Dr. Ulrich Abshagen. In addition to providing financial capital, Heidelberg Innovation's 'network and knowledge capital', in the form of entrepreneurial experience, technical expertise and their network of experts and contacts, is a decisive added value for their investee companies. Based in Leimen, the firm manages the Heidelberg Innovation BioScience Venture II, Heidelberg Innovation Parallel Participation and the Heidelberg Innovation BioScience Venture I funds for investors including the European Investment Fund, insurance companies, banks, fund-of-fund investors and private individuals. | Private Equity Investor | 01/07/2007 |
Luciole Medical AG
 Luciole Medical AG Packaged SoftwareTechnology Services Luciole Medical AG operates as a Swiss medical technology company developing brain oxygenation monitoring systems. The firm's products include Rheopatch, RheoSens, RheoLity and RheoControl. The company was founded in September 2017 and is headquartered in Zurich, Switzerland. | Directeur/Membre du Conseil | - |
Eurofins BioPharma Services Holding Germany GmbH
 Eurofins BioPharma Services Holding Germany GmbH Investment ManagersFinance Part of Eurofins Scientific SE, Eurofins BioPharma Services Holding Germany GmbH provides investment services. The company is based in Planegg, Germany. The CEOs of the German company are Marco Antonio Guiseppe Baeli, Tomasz Bednarczyk P. | Directeur Général | - |
Formation de Berthold Hackl
| INSEAD | Masters Business Admin |
| University of Freiburg | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Heidelberg Innovation Fonds Management GmbH
Heidelberg Innovation Fonds Management GmbH Investment ManagersFinance Heidelberg Innovation Fonds Management GmbH (Heidelberg Innovation) is an independent German venture capital firm which was founded in 1997 by Dr. Ulrich Abshagen. In addition to providing financial capital, Heidelberg Innovation's 'network and knowledge capital', in the form of entrepreneurial experience, technical expertise and their network of experts and contacts, is a decisive added value for their investee companies. Based in Leimen, the firm manages the Heidelberg Innovation BioScience Venture II, Heidelberg Innovation Parallel Participation and the Heidelberg Innovation BioScience Venture I funds for investors including the European Investment Fund, insurance companies, banks, fund-of-fund investors and private individuals. | Finance |
Arthro Kinetics Ltd.
Arthro Kinetics Ltd. Medical SpecialtiesHealth Technology Arthro Kinetics develops manufactures and markets advanced biological implants for joint regeneration and surgical instrument and access systems for endoscopic spine surgery. The Company aims to develop a portfolio of biological implants for insertion by endoscopic spine surgery techniques, thereby setting new standards of surgical care. The Company has developed and is marketing CaReS, its first biological cartilage repair product, and K.I.S.S., its comprehensive spinal surgical instruments system for endoscopic spinal access and surgical intervention. | Health Technology |
Ambu Innovation GmbH
 Ambu Innovation GmbH Medical SpecialtiesHealth Technology Ambu Innovation GmbH engages in the development and distribution of single-use and light-weight robotically-assisted high definition endoscopy products in the field of gastroenterology and gastro-intestinal surgery. Its products include invendoscope SC210, invendo ScopeController, and invendo SPU E210. The company was founded in 1992 and is headquartered in Kissing, Germany. | Health Technology |
mtm laboratories AG
mtm laboratories AG Medical SpecialtiesHealth Technology mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec® Histology kit and CINtec® Cytology kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4™ antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results. mtm laboratories AG also has programs to identify and develop biomarker based diagnostics for other cancer indications. With its extensive and ever increasing network of clinical research institutions, academic research organizations, and medical professionals active in the field of oncology and molecular pathology, mtm has established a rapid, integrated process for the successful identification and clinical validation of molecular markers associated with cancer. | Health Technology |
Sorrento Investment GmbH
Sorrento Investment GmbH MiscellaneousMiscellaneous Sorrento Investment GmbH operates as a holding company. The company was founded in May 2006 and is headquartered in Kronberg im Taunus, Germany. | Miscellaneous |
Arthro Kinetics AG
 Arthro Kinetics AG BiotechnologyHealth Technology Arthro Kinetics AG researches, develops, manufactures and sells biological implants. The company was founded in 1999 and is headquartered in Bebenhausen, Germany. | Health Technology |
Eurofins BioPharma Services Holding Germany GmbH
Eurofins BioPharma Services Holding Germany GmbH Investment ManagersFinance Part of Eurofins Scientific SE, Eurofins BioPharma Services Holding Germany GmbH provides investment services. The company is based in Planegg, Germany. The CEOs of the German company are Marco Antonio Guiseppe Baeli, Tomasz Bednarczyk P. | Finance |
Luciole Medical AG
Luciole Medical AG Packaged SoftwareTechnology Services Luciole Medical AG operates as a Swiss medical technology company developing brain oxygenation monitoring systems. The firm's products include Rheopatch, RheoSens, RheoLity and RheoControl. The company was founded in September 2017 and is headquartered in Zurich, Switzerland. | Technology Services |
